Cannabis Focused Private Credit
A differentiated, senior secured direct lending strategy for investors who seek consistent cash income, principal protection, and equity upside, with low correlation to other asset classes.
A cannabis focused private credit strategy seeking attractive risk-adjusted returns while focusing on capital preservation and consistent income generation. The strategy predominantly invests in senior-secured loans to middle market companies in the cannabis industry.
%
PREFERRED RETURN
%
ANNUAL CASH DISTRIBUTIONS
%+
SENIOR SECURED
AVERAGE LOAN DURATION (MONTHS)

The Cannabis Investment Opportunity
We pursue niche markets overlooked by traditional capital sources—where inefficiencies, limited funding, and mispriced risk create outsized potential. The cannabis space offers structural advantages, emerging regulatory shifts, and constrained competition that can drive strong, uncorrelated, risk-adjusted returns.
- LACK OF TRADITIONAL FINANCING
Banks generally don’t lend to firms in this industry, allowing higher interest rates, attractive collateral, and lender-friendly covenants. - HIGH BARRIERS TO ENTRY
Each state has unique investment characteristics, supply and demand dynamics, and legal frameworks, requiring sophisticated understanding of the industry and strong underwriting expertise. - LOW CORRELATIONS TO TRADITIONAL MARKETS
Medical cannabis behaves like pharmaceuticals, recreational cannabis behaves like tobacco and alcohol, both exhibiting low correlation with traditional markets. - FOCUS ON LIMITED LICENSE STATES
Limited license states have limited competition, lucrative license values, high wholesale prices, and less black market presence. - NEAR TERM CATALYSTS
Potential scheduling of cannabis from a schedule 1 to a schedule 3 substance would decrease the tax burden of cannabis operators, improve profitability, and create greater access to capital.
The Cannabis Landscape in the U.S is Evolving
Legal in 35 states and the District of Columbia1
- Medical use only: 25 states
- Recreational/Medical use: 10 states & District of Columbia
Legal in 42 states and the District of Columbia1
- Medical use only: 18 states
- Recreational/Medical use: 24 states & District of Columbia
1 MJ Biz Factbook Q1 2025

Our Differentiators
